2BB score and signals
Greenwich LifeSciences, Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 47 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 20 | Weak |
| Risk | 0 | Very Low |
Company facts
| Headquarters | Stafford, Texas, United States |
| Founded | 2006 |
| Employees | 4 |
| 52-week range | $7.78 – $34.10 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-12 | — | -0.3417 | — | $0.00 |
| 2026-08-12 | — | -0.3366 | — | $0.00 |
| 2026-05-18 | — | -0.3366 | — | $0.00 |
| 2026-04-13 | — | -0.3264 | — | $0.00 |